By Physicians for Informed Consent
Breaking News, Newport Beach, CA: Physicians for Informed Consent Publishes New Educational Document on Risk of Aluminum in Vaccines
Physicians for Informed Consent (PIC), an educational nonprofit organization focused on science and statistics, has just released its Aluminum Vaccine Risk Statement (VRS) entitled “Aluminum in Vaccines: What Parents Need to Know.” The educational document answers important questions about the risks of aluminum-containing vaccines administered to newborns, infants and children.
“The COVID-19 pandemic has shown us that the public is very interested in weighing the risks of infectious diseases versus the risks of vaccines,” said Dr. Shira Miller, PIC founder and president. “Parents and the public must become knowledgeable about aluminum in vaccines because even though it is used as an adjuvant in many vaccines, it is a neurotoxin—and overexposure may lead to significant harm, including problems in motor, sensory, and cognitive function.” Currently, up to 22 doses of aluminum-containing vaccines are recommended to children, with 11 doses recommended from birth to 6 months of age.
The U.S. Food and Drug Administration (FDA) and the Agency for Toxic Substances and Disease Registry (ATSDR), agencies of the U.S. Department of Health and Human Services (HHS), have raised concerns about the negative effects of aluminum exposure in humans. In scientific studies, small amounts of aluminum that remain in the body have been observed to interfere with a variety of cellular and metabolic processes in the nervous system and in tissues of other parts of the body. Some of the most damaging effects of aluminum range from motor skill impairment to encephalopathy (altered mental state, personality changes, difficulty thinking, loss of memory, seizures, coma, and more).
The FDA states that if some vaccines did not include aluminum (i.e., aluminum hydroxide and aluminum phosphate) as an adjuvant, the immune response they trigger may be diminished. Therefore, aluminum is included in many vaccines on the childhood schedule, including the following: hepatitis B (HepB), Haemophilus influenzae type b (PedvaxHIB), pneumococcal (PCV), hepatitis A (HepA), human papillomavirus (HPV), meningococcal B (MenB), and diphtheria, tetanus, and pertussis (DTaP and Tdap).
“Vaccines are administered preventively to healthy people, not people with acute or chronic infections, so it’s crucially important to know the safety data upon which one’s recommendations are based,” said Dr. Miller. “PIC developed the Aluminum VRS to help families and their physicians advance their understanding of the risks of aluminum adjuvants, so they may engage in informed decision-making.”
Parents and caregivers are encouraged to discuss the Aluminum VRS educational documents with their children’s doctor.
To read the Aluminum VRS or to download it, please visit http://physiciansforinformedconsent.org/aluminum.
PLEASE NOTE: The content, ideas, and views in this article are those of the presenter(s); Arvesa does not claim ownership of the content or the information provided above. Arvesa’s intention in sharing information is to provide access to said information so that viewers may come to their own informed conclusion(s).
FAIR-USE COPYRIGHT DISCLAIMER: Copyright Disclaimed under Section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, commenting, news reporting, teaching, scholarship and research. Fair use, including that of educational or personal use, is a use as permitted by copyright statute. Arvesa has uploaded this information as to preserve its integrity for educational purposes. Therefore, the use of material in this post constitutes a ‘FAIR USE’ of any such copyrighted material; the martial in this article is for research and educational purposes only.
Comments